Michael Shawn Moran

EVP, Chief Commercial Officer, EAGLE PHARMACEUTICALS, INC.

Companies

EAGLE PHARMACEUTICALS, INC.EVP, Chief Commercial Officer Oct 7, 2021 to Mar 2, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

EAGLE PHARMACEUTICALS, INC.32,115 shares²Feb 28, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 28, 2022Granted 10,400 shares of EAGLE PHARMACEUTICALS, INC.²
Feb 2, 2022Shares withheld for tax 742 shares at $45.03 of EAGLE PHARMACEUTICALS, INC.³
Jan 31, 2022Shares withheld for tax 210 shares at $45.94 of EAGLE PHARMACEUTICALS, INC.⁴
Jan 7, 2022Shares withheld for tax 90 shares at $50.63 of EAGLE PHARMACEUTICALS, INC.⁵
Jan 5, 2022Shares withheld for tax 1,511 shares at $50.69 of EAGLE PHARMACEUTICALS, INC.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREAGLE PHARMACEUTICALS, INC., EVP, Chief Commercial Officer
2
SEC EDGAREAGLE PHARMACEUTICALS, INC. shares after the filing of Feb 28, 2022
3
SEC EDGARForm 4 filed Feb 4, 2022
4
SEC EDGARForm 4 filed Feb 1, 2022
5
SEC EDGARForm 4 filed Jan 11, 2022
6
SEC EDGARForm 4 filed Jan 7, 2022